279 related articles for article (PubMed ID: 29974234)
1. Upregulation of insulin-like growth factor II mRNA-binding protein 3 (IMP3) has negative prognostic impact on early invasive (pT1) adenocarcinoma of the esophagus.
Plum PS; Ulase D; Bollschweiler E; Chon SH; Berlth F; Zander T; Alakus H; Hölscher AH; Bruns CJ; Schallenberg S; Quaas A; Loeser H
J Cancer Res Clin Oncol; 2018 Sep; 144(9):1731-1739. PubMed ID: 29974234
[TBL] [Abstract][Full Text] [Related]
2. Role of lymphovascular invasion and immunohistochemical expression of IMP3 in the risk stratification of superficially invasive pT1 esophageal adenocarcinoma.
Trivedi A; Cartun RW; Ligato S
Pathol Res Pract; 2014 Jul; 210(7):402-6. PubMed ID: 24726263
[TBL] [Abstract][Full Text] [Related]
3. HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma.
Plum PS; Gebauer F; Krämer M; Alakus H; Berlth F; Chon SH; Schiffmann L; Zander T; Büttner R; Hölscher AH; Bruns CJ; Quaas A; Loeser H
BMC Cancer; 2019 Jan; 19(1):38. PubMed ID: 30621632
[TBL] [Abstract][Full Text] [Related]
4. Expression of insulin-like growth factor II mRNA-binding protein 3 in human esophageal adenocarcinoma and its precursor lesions.
Feng W; Zhou Z; Peters JH; Khoury T; Zhai Q; Wei Q; Truong CD; Song SW; Tan D
Arch Pathol Lab Med; 2011 Aug; 135(8):1024-31. PubMed ID: 21809994
[TBL] [Abstract][Full Text] [Related]
5. Early-stage adenocarcinoma of the esophagus with mid to deep submucosal invasion (pT1b sm2-3): the frequency of lymph-node metastasis depends on macroscopic and histological risk patterns.
Manner H; Wetzka J; May A; Pauthner M; Pech O; Fisseler-Eckhoff A; Stolte M; Vieth M; Lorenz D; Ell C
Dis Esophagus; 2017 Feb; 30(3):1-11. PubMed ID: 26952572
[TBL] [Abstract][Full Text] [Related]
6. Molecular markers predicting lymph node metastasis in early esophageal cancer.
Plum PS; Warnecke-Eberz U; Dhaouadi O; Alakus H; Drebber U; Metzger R; Prenzel KL; Hölscher AH; Bollschweiler E
Histol Histopathol; 2015 Oct; 30(10):1193-202. PubMed ID: 25869644
[TBL] [Abstract][Full Text] [Related]
7. Diffuse expression of RNA-binding protein IMP3 predicts high-stage lymph node metastasis and poor prognosis in colorectal adenocarcinoma.
Yuan RH; Wang CC; Chou CC; Chang KJ; Lee PH; Jeng YM
Ann Surg Oncol; 2009 Jun; 16(6):1711-9. PubMed ID: 19357927
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of upper, middle, and lower third mucosal or submucosal infiltration in early esophageal cancer.
Hölscher AH; Bollschweiler E; Schröder W; Metzger R; Gutschow C; Drebber U
Ann Surg; 2011 Nov; 254(5):802-7; discussion 807-8. PubMed ID: 22042472
[TBL] [Abstract][Full Text] [Related]
9. Olfactomedin 4 (OLFM4) expression is associated with nodal metastases in esophageal adenocarcinoma.
Suzuki L; Ten Kate FJC; Gotink AW; Stoop H; Doukas M; Nieboer D; Spaander MCW; van Lanschot JJB; van Wijnhoven BPL; Koch AD; Bruno MJ; Looijenga LHJ; Biermann K
PLoS One; 2019; 14(7):e0219494. PubMed ID: 31283789
[TBL] [Abstract][Full Text] [Related]
10. Predictors of Lymph Node Metastasis in Surgically Resected T1 Esophageal Cancer.
Dubecz A; Kern M; Solymosi N; Schweigert M; Stein HJ
Ann Thorac Surg; 2015 Jun; 99(6):1879-85; discussion 1886. PubMed ID: 25929888
[TBL] [Abstract][Full Text] [Related]
11. IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis.
Li D; Yan D; Tang H; Zhou C; Fan J; Li S; Wang X; Xia J; Huang F; Qiu G; Peng Z
Ann Surg Oncol; 2009 Dec; 16(12):3499-506. PubMed ID: 19672661
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of insulin-like growth factor II mRNA-binding protein 3 (IMP3) as a new marker for the diagnosis of esophageal adenocarcinoma in challenging cases.
Kazeminezhad B; Mirafsharieh SA; Dinyari K; Azizi D; Ebrahimi A
Turk J Gastroenterol; 2014 Jun; 25(3):253-6. PubMed ID: 25141312
[TBL] [Abstract][Full Text] [Related]
13. Tumor-specific Expression of Insulin-like Growth Factor II mRNA-binding Protein 3 Independently Predicts Worse Survival of Patients With Adenocarcinoma of the Ampulla of Vater.
Kim HG; Park MS; Sung JY; Kim YW; Kim HS; Na K
Anticancer Res; 2019 Sep; 39(9):4947-4955. PubMed ID: 31519600
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma a retrospective review of esophagectomy specimens.
Leers JM; DeMeester SR; Oezcelik A; Klipfel N; Ayazi S; Abate E; Zehetner J; Lipham JC; Chan L; Hagen JA; DeMeester TR
Ann Surg; 2011 Feb; 253(2):271-8. PubMed ID: 21119508
[TBL] [Abstract][Full Text] [Related]
15. Limited resection for early adenocarcinoma in Barrett's esophagus.
Stein HJ; Feith M; Mueller J; Werner M; Siewert JR
Ann Surg; 2000 Dec; 232(6):733-42. PubMed ID: 11088068
[TBL] [Abstract][Full Text] [Related]
16. Prediction model of lymph node metastasis in superficial esophageal adenocarcinoma and squamous cell cancer including D2-40 immunostaining.
Gockel I; Domeyer M; Sgourakis GG; Schimanski CC; Moehler M; Kirkpatrick CJ; Lang H; Junginger T; Hansen T
J Surg Oncol; 2009 Sep; 100(3):191-8. PubMed ID: 19548259
[TBL] [Abstract][Full Text] [Related]
17. IMP3 Predicts Invasion and Prognosis in Human Lung Adenocarcinoma.
Yan J; Wei Q; Jian W; Qiu B; Wen J; Liu J; Fu B; Zhou X; Zhao T
Lung; 2016 Feb; 194(1):137-46. PubMed ID: 26608347
[TBL] [Abstract][Full Text] [Related]
18. Duplicated muscularis mucosae invasion has similar risk of lymph node metastasis and recurrence-free survival as intramucosal esophageal adenocarcinoma.
Estrella JS; Hofstetter WL; Correa AM; Swisher SG; Ajani JA; Lee JH; Bhutani MS; Abraham SC; Rashid A; Maru DM
Am J Surg Pathol; 2011 Jul; 35(7):1045-53. PubMed ID: 21602659
[TBL] [Abstract][Full Text] [Related]
19. T1 squamous cell carcinoma of the esophagus: long-term outcomes and prognostic factors after esophagectomy.
Tanaka T; Matono S; Mori N; Shirouzu K; Fujita H
Ann Surg Oncol; 2014 Mar; 21(3):932-8. PubMed ID: 24232603
[TBL] [Abstract][Full Text] [Related]
20. Expression of Insulin-like Growth Factor II mRNA-binding Protein 3 in Gallbladder Carcinoma.
Kim SJ; Kim SW; Oh CH; Hong M; DO SI; Kim YW; Kim HS; Na K
Anticancer Res; 2020 Oct; 40(10):5777-5785. PubMed ID: 32988905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
